Literature DB >> 2342514

An increased risk for malignant neoplasms in heterozygotes for a syndrome of microcephaly, normal intelligence, growth retardation, remarkable facies, immunodeficiency and chromosomal instability.

E Seemanová1.   

Abstract

We have collected and studied the genealogical data of 8 patients with the autosomal recessive syndrome of microcephaly, normal intelligence, immunodeficiency, risk of malignancy and chromosomal instability resembling ataxia telangiectasia (AT), but different in complementation group. 50% of our probands died from lymphoreticular malignancies in early childhood. We have found a significantly increased incidence of malignant tumors in 142 blood relatives as compared with a control group of 87 spouses. All patients belonged to the same complementation group differing from the 5 known AT complementation groups, which seems to be in general more malignant than all other groups of AT. From this standpoint our material is homogeneous in contrast to other similar studies in AT families. We think this syndrome represents another model to examine the relationship between genetic background, chromosomal abnormalities, immunodeficiency and cancer development.

Entities:  

Mesh:

Year:  1990        PMID: 2342514     DOI: 10.1016/0165-1110(90)90024-6

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  13 in total

1.  High prevalence of the NBN gene mutation c.657-661del5 in Southeast Germany.

Authors:  M H Maurer; K Hoffmann; K Sperling; R Varon
Journal:  J Appl Genet       Date:  2010       Impact factor: 3.240

2.  The gene for the ataxia-telangiectasia variant, Nijmegen breakage syndrome, maps to a 1-cM interval on chromosome 8q21.

Authors:  K Saar; K H Chrzanowska; M Stumm; M Jung; G Nürnberg; T F Wienker; E Seemanová; R D Wegner; A Reis; K Sperling
Journal:  Am J Hum Genet       Date:  1997-03       Impact factor: 11.025

3.  Ataxia-telangiectasia: linkage analysis in highly inbred Arab and Druze families and differentiation from an ataxia-microcephaly-cataract syndrome.

Authors:  Y Ziv; M Frydman; E Lange; N Zelnik; G Rotman; C Julier; N G Jaspers; Y Dagan; D Abeliovicz; H Dar; Z Borochowitz; M Lathrop; R A Gatti; Y Shiloh
Journal:  Hum Genet       Date:  1992-03       Impact factor: 4.132

4.  First case of aplastic anemia in a Japanese child with a homozygous missense mutation in the NBS1 gene (I171V) associated with genomic instability.

Authors:  Hiroyuki Shimada; Kimiko Shimizu; Sachiyo Mimaki; Tokuki Sakiyama; Tetsuya Mori; Noriko Shimasaki; Jun Yokota; Kei Nakachi; Tsutomu Ohta; Misao Ohki
Journal:  Hum Genet       Date:  2004-08-24       Impact factor: 4.132

5.  A Recurrent ERCC3 Truncating Mutation Confers Moderate Risk for Breast Cancer.

Authors:  Joseph Vijai; Sabine Topka; Danylo Villano; Vignesh Ravichandran; Kara N Maxwell; Ann Maria; Tinu Thomas; Pragna Gaddam; Anne Lincoln; Sarah Kazzaz; Brandon Wenz; Shai Carmi; Kasmintan A Schrader; Steven N Hart; Steve M Lipkin; Susan L Neuhausen; Michael F Walsh; Liying Zhang; Flavio Lejbkowicz; Hedy Rennert; Zsofia K Stadler; Mark Robson; Jeffrey N Weitzel; Susan Domchek; Mark J Daly; Fergus J Couch; Katherine L Nathanson; Larry Norton; Gad Rennert; Kenneth Offit
Journal:  Cancer Discov       Date:  2016-09-21       Impact factor: 39.397

6.  DNA damage responses in Drosophila nbs mutants with reduced or altered NBS function.

Authors:  Sushmita Mukherjee; Matthew C LaFave; Jeff Sekelsky
Journal:  DNA Repair (Amst)       Date:  2009-04-22

7.  Identification of a novel NBN truncating mutation in a family with hereditary prostate cancer.

Authors:  Kimberly A Zuhlke; Anna M Johnson; Linda A Okoth; Elena M Stoffel; Christiane M Robbins; Waibov A Tembe; Claudia A Salinas; S Lilly Zheng; Jianfeng Xu; John D Carpten; Ethan M Lange; William B Isaacs; Kathleen A Cooney
Journal:  Fam Cancer       Date:  2012-12       Impact factor: 2.375

8.  NBS1 Heterozygosity and Cancer Risk.

Authors:  Alessandra di Masi; Antonio Antoccia
Journal:  Curr Genomics       Date:  2008-06       Impact factor: 2.236

9.  Variations in the NBN/NBS1 gene and the risk of breast cancer in non-BRCA1/2 French Canadian families with high risk of breast cancer.

Authors:  Sylvie Desjardins; Joly Charles Beauparlant; Yvan Labrie; Geneviève Ouellette; Francine Durocher
Journal:  BMC Cancer       Date:  2009-06-12       Impact factor: 4.430

Review 10.  Hereditary breast cancer: the era of new susceptibility genes.

Authors:  Paraskevi Apostolou; Florentia Fostira
Journal:  Biomed Res Int       Date:  2013-03-21       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.